Dr. Marks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5115 Centre Ave
3rd Floor
Pittsburgh, PA 15232Phone+1 412-235-1077Fax+1 412-235-1030- Is this information wrong?
Summary
- Dr. Stanley Marks is an oncologist in Pittsburgh, PA and is affiliated with multiple hospitals in the area, including UPMC Presbyterian, Shadyside Campus, and UPMC Magee-Womens Hospital. He received his medical degree from University of Pittsburgh School of Medicine and has been in practice 44 years. He is experienced in hematologic oncology and acute myeloid leukemia.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1976 - 1978
- UPMC Medical EducationResidency, Internal Medicine, 1973 - 1976
- University of Pittsburgh School of MedicineClass of 1973
Certifications & Licensure
- PA State Medical License 1974 - 2024
- OH State Medical License 1991 - 2000
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Publications & Presentations
PubMed
- Results from a Real-World Multicenter Analysis of 482 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Look at Racial Differences.Jacqueline C Barrientos, Ayed O Ayed, Agnes Cha, Senxi Du, Bruno Fang, Ryan Hall, Stanley M Marks, Eileen Peng, Joanna M Rhodes, Kellie Ryan, Sharon B Winters, Percy L...> ;Targeted Oncology. 2023 Sep 1
- 37 citationsProspective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in t...Ghady Haidar, Mounzer Agha, Andrew Bilderback, Amy Lukanski, Kelsey Linstrum, Rachel Troyan, Scott Rothenberger, Deborah K McMahon, Melissa D Crandall, Michele D Sobol...> ;Clinical Infectious Diseases. 2022 Aug 24
- 25 citationsPembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis.Kuang, C., Park, Y., Augustin, R., Lin, Y., Hartman, D., Seigh, L., Pai, R., Sun, W., Bahary, N., Ohr, J., Rhee, J., Marks, S., Beasley, H., Shuai, Y., Herman, J., Zar...> ;Clinical Epigenetics. 2022 Jan 6
- Join now to see all
Press Mentions
- National Drug Shortage Impacting Cancer Care at UPMCMay 25th, 2023
- Satchels of Caring Foundation Closing After Nearly 2 Decades Giving Hope to Cancer PatientsFebruary 22nd, 2022
- Health Experts Say Evusheld Is Effective Against Fighting COVID-19February 1st, 2022
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- UPMC Presbyterian ShadysidePittsburgh, Pennsylvania
- Shadyside CampusPittsburgh, Pennsylvania
- UPMC Magee-Womens HospitalPittsburgh, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: